Researchers leverage studies in fruit flies to identify a potential treatment for people with neurodegenerative disorder called spinocerebellar ataxia.
Proteins that guide transcription factors from the nuclear membrane to the DNA cause drug-resistant skin cancers and are new targets for drug development.
Honeybee royal jelly affects the developmental potential of mouse stem cells. A structurally similar protein in mammals could aid stem cell research.
Abdominal adhesions can have lasting, significant consequences. Now Stanford researchers have identified the cells responsible and a possible treatment.
DNA looping, or folding, directs a cell's developmental fate. Harnessing this 'DNA origami' could help researchers generate specific tissues for therapies.
Is extensive regeneration possible in humans? Stanford researchers show skeletal stem cells can move backward developmentally when major repairs are needed.
A Stanford team has developed an algorithm that uses data about tumors to identify new classifications that can provide information about patient outcomes
A Stanford-designed computer algorithm helps doctors predict the lifespan of patients with metastatic cancer by looking for clues in their own exam notes.
Stanford researchers have learned that cancer cells can batter their way into new territory, rather than relying on dissolving chemicals.
'Mitotic catastrophe' hampers the ability of aged muscle stem cells to repair damage. Manipulating this process could lead to new therapies for old muscle.
Hiding mRNA messages in CARTs — positively charged degradable vehicles —smuggles them across the cell membrane and can 'vaccinate' against cancer in mice.
Discovery of the human skeletal stem cell opens the way to regenerate cartilage and bone to repair damaged tissues, say Stanford scientists.
Online outreach and low-cost testing can encourage relatives of cancer patients to assess their own cancer risk through 'cascade' testing.
Mapping the geography of the immune response in triple negative breast cancers predicts patient survival and sheds light onto new aspects of tumor biology.
Heart muscle cells from people with cardiomyopathies have shorter-than-normal telomeres -- the protective caps on chromosomes associated with aging.
Monitoring changes in the levels of circulating bits of tumor DNA may help some lymphoma patients avoid unnecessary chemotherapy, Stanford researchers find.
